LYNX CAPITAL GROUP LTD /ADV’s Medtronic MDT Stock Holding History

LYNX CAPITAL GROUP LTD /ADV’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$2.22M	Buy	+26,950	New	+$2.05M	1.62%	31

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LYNX CAPITAL GROUP LTD /ADV's MDT Position: Q4 2023 in Review

LYNX CAPITAL GROUP LTD /ADV opened a new position in Medtronic (MDT) in Q4 2023: 26,950 shares worth $2.22M. The stake represents 1.62% of the portfolio and ranks #31 among its holdings.

2,077 funds tracked by Wall St. Rank hold MDT as of Q4 2023.

LYNX CAPITAL GROUP LTD /ADV held 26,950 shares of Medtronic worth $2.22M as of Q4 2023.
Medtronic was a new LYNX CAPITAL GROUP LTD /ADV position in Q4 2023.
Medtronic made up 1.62% of LYNX CAPITAL GROUP LTD /ADV's portfolio in Q4 2023, its #31 holding.
2,077 funds tracked by Wall St. Rank held Medtronic as of Q4 2023.

Based on LYNX CAPITAL GROUP LTD /ADV's 13F filing for Q4 2023, filed 7 Aug 2026.